All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 171 of 206 pages ‹ First < 169 170 171 172 173 > Last ›
HSL8222
Wechsler J.
Final reform bill modernizes FDA, permits dissemination of off-label and economic data
Formulary 1997 Dec;32:1253-1254
HSL8240
Hicks AR, Jackson MW, Barnard JF.
Pharmacoeconomic strategies for treating HIV patients in an indigent clinic
ASHP Midyear Clinical Meeting 1997 Dec;32:
HSL8241
Habowski SR, Robinson SM, Kalis D.
Establishing an indigent prescription program in the ambulatory care setting
ASHP Midyear Clinical Meeting 1997 Dec;32:
HSL13248
Aaker JL, Maheswaran D.
The Effect of Cultural Orientation on Persuasion
Journal of Consumer Research 1997 Dec;24:(3):315-27
http://www.journals.uchicago.edu/doi/abs/10.1086/209513
HSL580
Alliot L.
Quality of drug advertisements in medical journals.
Lancet 1997 Nov 29;350:(9091):1636
HSL20197
Kavoc C
SmithKline Beecham fined in Hungary
BMJ 1997 Nov 29;315:
http://www.bmj.com/content/315/7120/1397.13
HSL6768
Chiu JT.
Personal use of drug samples by physicians and office staff.
JAMA 1997 Nov 19;278:(19):1568
HSL6769
Limaye AP, Paauw DS.
Personal use of drug samples by physicians and office staff.
JAMA 1997 Nov 19;278:(19):1568-9
HSL6770
Margolis LH.
Personal use of drug samples by physicians and office staff.
JAMA 1997 Nov 19;278:(19):1567
HSL6771
Mehta HJ.
Personal use of drug samples by physicians and office staff.
JAMA 1997 Nov 19;278:(19):1568
HSL6772
Reynolds S.
Personal use of drug samples by physicians and office staff.
JAMA 1997 Nov 19;278:(19):1567-8
HSL6773
Rosner F.
Personal use of drug samples by physicians and office staff.
JAMA 1997 Nov 19;278:(19):1567
HSL6774
Tenery RM Jr.
Personal use of drug samples by physicians and office staff.
JAMA 1997 Nov 19;278:(19):1568
HSL6775
Westfall J, McCabe J, Nicholas RA.
Personal use of drug samples by physicians and office staff [reply]
JAMA 1997 Nov 19;278:(19):1569
HSL418
Vitry A, Mansfield P.
Drug advertisements in medical journals.
Lancet 1997 Nov 15;350:(9089):1477-8
http://www.thelancet.com/search/results?search_searchuri=%2Fsearch%2Fadvanced&search_resulturi=%2Fsearch%2Fresults&search_preview=no&search_reqfirst=1&search_reqcount=20&search_submode=advanced&update_search=no&search_mode=platform&search_cluster=phoenix&search_text1=Vitry+A&search_within1=au&search_operator1=and&search_text2=Mansfield+P&search_within2=au&search_operator2=and&search_text3=advertisements&search_within3=ti&restrictterm_lancet=lancet&restrictname_lancet=lancet&restricttype_lancet=journal&restrictdesc_lancet=The+Lancet&restrictname_laneur=laneur&restricttype_laneur=journal&restrictdesc_laneur=The+Lancet+Neurology&restrictname_laninf=laninf&restricttype_laninf=journal&restrictdesc_laninf=The+Lancet+Infectious+Diseases&restrictname_lanonc=lanonc&restricttype_lanonc=journal&restrictdesc_lanonc=The+Lancet+Oncology&search_dateradio=combo&search_datecombo=0%3AALL&search_monthstartcombo=1&search_yearstart=1996&search_monthendcombo=1&search_yearend=2005&search_wordsexactly=yes&search_sort=relevance&Submit=Search
HSL564
Flegel KM.
Physicians, finder's fees and free, informed consent.
CMAJ 1997 Nov 15;157:(10):1373-4
http://www.cma.ca/cmaj/vol-157/issue-10/1373.htm
HSL8230
Rothermich EA, Pathak DS.
References for health-related quality-of-life claims in prescription drug advertisements.
Am J Health Syst Pharm 1997 Nov 15;54:(22):2596-9
http://www.ajhp.org/cgi/reprint/54/22/2596
HSL18030
Dent TH, Hawke S.
Too soon to market.
BMJ 1997 Nov 15;315:(7118):1248-9
http://www.bmj.com/cgi/content/full/315/7118/1248?view=long&pmid=9390044
HSL16732
Sasich LD, Wolfe SM, Pearson C, Swankin DA, Levin AA, Beard J.
The National Council on Patient Information and Education.
JAMA 1997 Nov 12;278:(18):1491-2
http://www.ncbi.nlm.nih.gov/pubmed/9363963
HSL545
Lexchin J.
Code of marketing practices.Voluntary self-regulation for the Pharmaceutical Manufacturers Association of Canada
Can Fam Physician. 1997 11 01;43:
HSL560
Guyatt G.
Determining an ethical stance: Pharmaceutical industry involvement and family medicine residency training
Can Fam Physician 1997 Nov 01;43:1898-900
HSL540
Mahood S, Zagozeski C, Bradel T, Lawrence K.
Pharmaceutical policies in Canadian family medicine training. Survey of residency programs
Can Fam Physician 1997 Nov;43:1947-51
HSL1866
Shaughnessy AF, Bucci KK.
Drug samples and family practice residents.
Ann Pharmacother 1997 Nov;31:(11):1296-300
HSL6762
Christensen TP, Ascione FJ, Bagozzi RP.
Understanding how elderly patients process drug information: a test of a theory of information processing.
Pharm Res 1997 Nov;14:(11):1589-96
http://www.springerlink.com/content/j710827lt8226251/
HSL6763
Lumley P.
Forging closer links with patients
Scrip Magazine 1997 Nov;(62):19-20
www.pjbpubs.co.uk/scrip/scrhome.html
HSL6764
Prettejohn R.
Making the most of meetings
Scrip Magazine 1997 Nov;(62):11-12
HSL6765
Sorell T.
Sponsors, ethics and the NHS
Scrip Magazine 1997 Nov;(62):7-9
www.pjbpubs.co.uk/scrip/scrhome.html
HSL6766
Weinblatt L.
DTC advertisers—you’re wasting your money
Medical Marketing & Media 1997 Nov;32:(11):47-51
HSL6767
Sweet M.
Healthy profits (part 3)
MaLAM International News 1997 Nov-Dec;15:(11-12):1-4
HSL8187
Maximize your prescription drug investment
Managed Healthcare 1997 Nov;7:46-47
HSL8189
McCann B.
How will FDA reform affect the generic industry?
Drug Topics 1997 Nov;141:
HSL8192
Akanmu O.
Nigeria-strategy and strength for industry
Pharmaceutical Executive 1997 Nov;17:74-78
HSL19944
Berzins K
Posing an objection
Australian Doctor 1997 Oct 31
HSL20018
Collings S
Drug rep's values
Australian Doctor 1997 Oct 31
HSL517
Sternberg EM.
Intimidation of researchers by special-interest groups.
N Engl J Med 1997 Oct 30;337:(18):1316
http://content.nejm.org/cgi/search?andorexactfulltext=and&andorexacttitleabs=and&excludeflag=TWEEK_element&search_tab=authors&searchtitle=Authors&hits=20&author1=Sternberg+EM&sendit=GO&author2=&fulltext=&sortspec=Score+desc+PUBDATE_SORTDATE+desc&fmonth=Jan&fyear=1997&tmonth=Dec&tyear=1997&tocsectionid=Original+Articles&tocsectionid=Special+Reports&tocsectionid=Special+Articles&tocsectionid=Images+in+Clinical+Medicine&tocsectionid=Clinical+Practice&tocsectionid=Case+Records+of+the+Massachusetts+General+Hospital&tocsectionid=Review+ArticlesAORBClinical+PracticeAORBClinical+Implications+of+Basic+ResearchAORBMolecular+Medicine&tocsectionid=Clinical+Problem-Solving&tocsectionid=EditorialsAORBPerspectiveAORBOutlookAORBBehind+the+Research&tocsectionid=Legal+Issues+in+Medicine&tocsectionid=Sounding+BoardAORBClinical+Debate&tocsectionid=Correspondence&tocsectionid=Clinical+Implications+of+Basic+Research&tocsectionid=Book+Reviews&tocsectionid=Health+Policy*AORBQuality+of+Health+Care&tocsectionid=Occasional+Notes
HSL562
Fardon DF, Garfin SR, Saal JA.
Intimidation of researchers by special-interest groups.
N Engl J Med 1997 Oct 30;337:(18):1315-6
HSL20502
Sweet M
Healthy Profits: Why your doctor is a pill pusher
The Sydney Morning Herald 1997 Oct 25
HSL2715
Katsanis , Prevel L, Olivanti , Christina C.
A review of patient education in promotional activities. Sponsored by the Canadian pharmaceutical industry: a descriptive study
1997 Oct 4;
http://www.fadmin.unb.ca/asb/paper42.htm
HSL8231
Talley CR.
Direct-to-consumer prescription drug advertising.
Am J Health Syst Pharm 1997 Oct 1;54:(19):2181
http://www.ajhp.org/cgi/reprint/54/19/2181
HSL19989
Lexchin J
Putting a price on drugs
CMAJ 1997 Oct 1;157:(7):869
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1228203/
HSL525
Sandberg WS, Carlos R, Sandberg EH, Roizen MF.
The effect of educational gifts from pharmaceutical firms on medical students' recall of company names or products.
Acad Med 1997 Oct;72:(10):916-8
HSL557
Hopper JA, Speece MW, Musial JL.
Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives.
J Gen Intern Med 1997 Oct;12:(10):639-42
HSL8184
Sims J.
Who will be able to prescribe?
Pharmacy in Practice 1997 Oct;7:497, 500, 502
HSL8199
Kauffman-Sherr M, Cutrone-Hoffman D
Physicians-gatekeepers to DTC success
Pharmaceutical Executive 1997 Oct;17:56-58, 62, 64, 66
HSL8200
Gopal K.
Patients as partners
Pharmaceutical Executive 1997 Oct;17:32, 34
HSL8214
Schwartz H.
On the money
Pharmaceutical Executive 1997 Oct;17:26, 28, 30
HSL8215
Madell R.
DTC unleashed: review & reactions
Pharmaceutical Executive 1997 Oct;17:68-70, 72, 74
HSL8216
Wechsler J.
Marketing to Medicare & Kiddie Care
Pharmaceutical Executive 1997 Oct;17:20, 22, 24
HSL8217
Wood J, Rupright P.
Erosion of the learned intermediary rule
Pharmaceutical Executive 1997 Oct;17:104, 106, 108, 110
HSL8227
Wechsler J.
Washington report: Medicare, child care and TV advertising
Pharmaceutical Technology Europe 1997 Oct;9:20, 22, 24, 26
HSL549
Langer A.
Early stopping of trials.
Lancet 1997 Sep 20;350:(9081):890-1
HSL558
Hopf G.
Early stopping of trials.
Lancet 1997 Sep 20;350:(9081):891
HSL16731
Lurie P, Wolfe SM.
Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries.
N Engl J Med 1997 Sep 18;337:(12):853-6
http://www.ncbi.nlm.nih.gov/pubmed/9295246
HSL518
Stern JM, Simes RJ.
Publication bias: evidence of delayed publication in a cohort study of clinical research projects.
BMJ 1997 Sep 13;315:(7109):640-5
http://bmj.bmjjournals.com/cgi/content/full/315/7109/640
HSL6760
Tramer MR, Reynolds DJ, Moore RA, McQuay HJ.
Impact of covert duplicate publication on meta-analysis: a case study.
BMJ 1997 Sep 13;315:(7109):635-40
http://bmj.com/cgi/content/full/315/7109/635, http://bmj.com/archive/7109/7109pr2.htm
HSL554
Hueston WJ, Mainous AG 3rd.
A comparison of the numbers of pharmaceutical advertising pages in family medicine research journals and journals in other medical disciplines.
Acad Med 1997 Sep;72:(9):804-6
HSL2328
Kazmierczak R, Coley KC.
Impact of Dear Doctor letters on prescribing: evaluation of the use of tramadol HCl
Formulary 1997 Sep;32:968, 977-978
HSL6756
Knowledge is the best medicine program launched in Quebec
PMAC News 1997 Sep-Oct;10-11
HSL6757
PMAC Code of Marketing Practices: amendments emphasize quality in continuing health education programs
PMAC News 1997 Sep-Oct;9
HSL6758
Sweet M.
Health profits (part 2)
MaLAM International News 1997 Sep-Oct;15:(9-10):1-4
HSL8114
Vaught DV.
Vaught's views
Illinois Pharmacist 1997 Sep-Oct;59:34-36
HSL18029
Cockburn J, Pit S.
Prescribing behaviour in clinical practice: patients' expectations and doctors' perceptions of patients' expectations--a questionnaire study.
BMJ 1997 Aug 30;315:(7107):520-3
http://www.bmj.com/cgi/content/full/315/7107/520?view=long&pmid=9329308
HSL563
Gitanjali B, Shashindran CH, Tripathi KD, Sethuraman KR.
Are drug advertisements in Indian edition of BMJ unethical?
BMJ 1997 Aug 23;315:(7106):459
http://www.bmj.com/cgi/content/full/315/7106/459
HSL572
Christo GG, Balasubramaniam R.
Commentary: advertising adversities.
BMJ 1997 Aug 23;315:(7106):460
http://www.bmj.com/cgi/content/full/315/7106/460
HSL6717
Greenhalgh T.
How to read a paper.
Papers that report drug trials 1997 Aug 23;
http://www.bmj.com/cgi/content/full/315/7106/480
HSL3685
FDA proposes new guidance on direct-to-consumer ads.
Scrip. 1997 Aug 15;2258:12
HSL13312
Wilke M.
GLaxo Pumps $55 Mil Into Zyban DTC Push: Anti-depressant Will Be Touted As Aid To Quit Smoking Cigarettes
Advertising Age 1997 Aug 11
http://adage.com/abstract.php?article_id=71118
HSL6755
Pill pushers
The Economist 1997 Aug 956-57
HSL8229
Raynor DK, Yerassimou N.
Medicines information--leaving blind people behind?
BMJ 1997 Aug 2;315:(7103):268
http://www.bmj.com/cgi/content/full/315/7103/268
HSL5348
Lupton D.
Consumerism, reflexivity and the medical encounter.
Soc Sci Med 1997 Aug 01;45:(3):373-81
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-3SWXX70-2F&_coverDate=08%2F31%2F1997&_alid=418727754&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5925&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=90880f1077985976a7488a05ece9b0c5
HSL8235
Schwartz DN.
Management of Helicobacter pylori-positive patients with dyspepsia.
Ann Intern Med 1997 Aug 1;127:(3):244
http://www.annals.org/cgi/content/full/127/3/244
HSL6754
Lexchin J, Vitry A.
Re: the promotion of Ambatrol (nifuroxazide)
1997 Aug;
HSL20236
McKenzie, CRM
Underweighting Alternative and Overconfidence
Organizational Behavior and Human Decision Processes 1997 Aug;71:(2):141-160
http://psycnet.apa.org/psycinfo/1997-43858-002
HSL19737
Willis J
You and patients can pull together
Pharmaceutical Marketing 1997 July 26
HSL6753
Vecchione A.
Direct concerns: Pharmacists wary of surge in consumer Rx drug ads
Drug Topics 1997 Jul 21;141:(14):36,37
HSL419
Viberti G, Slama G, Pozza G, Czyzyk A, Bilous RW, Gries A, Keen H, Fuller JH, Menzinger G.
Early closure of European Pimagedine trial. Steering Committee. Safety Committee.
Lancet 1997 Jul 19;350:(9072):214-5
http://linkinghub.elsevier.com/retrieve/pii/S0140673697260290
HSL421
A curious stopping rule from Hoechst Marion Roussel.
Lancet 1997 Jul 19;350:(9072):155
http://linkinghub.elsevier.com/retrieve/pii/S0140673697210299
HSL2089
Hemminki E, McPherson K.
Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials.
BMJ 1997 Jul 19;315:(7101):149-53
http://bmj.bmjjournals.com/cgi/content/full/315/7101/149
HSL19866
New Rules Imminent for Spanish Reps
Scrip 1997 July 18;2550:5
HSL8319
Thompson CA.
Drug information industry reacts to private-sector plan for useful content
American Journal of Health System Pharmacy 1997 Jul 15;54:1572, 1575
HSL521
Sharfstein J.
Pfizer Night at Boston Billiards.
N Engl J Med 1997 Jul 10;337:(2):134
http://content.nejm.org/cgi/search?andorexacttitleabs=and&tocsectionid=Original+Articles&tocsectionid=Special+Reports&tocsectionid=Special+Articles&tocsectionid=Images+in+Clinical+Medicine&tocsectionid=Clinical+Practice&tocsectionid=Case+Records+of+the+Massachusetts+General+Hospital&tocsectionid=Review+ArticlesAORBClinical+PracticeAORBClinical+Implications+of+Basic+ResearchAORBMolecular+Medicine&tocsectionid=Clinical+Problem-Solving&tocsectionid=EditorialsAORBPerspectiveAORBOutlookAORBBehind+the+Research&tocsectionid=Legal+Issues+in+Medicine&tocsectionid=Sounding+BoardAORBClinical+Debate&tocsectionid=Correspondence&tocsectionid=Clinical+Implications+of+Basic+Research&tocsectionid=Book+Reviews&tocsectionid=Health+Policy*AORBQuality+of+Health+Care&tocsectionid=Occasional+Notes&tmonth=Dec&searchtitle=Articles&sortspec=Score+desc+PUBDATE_SORTDATE+desc&excludeflag=TWEEK_element&hits=20&where=fulltext&tyear=1997&andorexactfulltext=and&fyear=1997&fmonth=Jan&search_tab=articles&searchterm=Pfizer+night&sendit=GO
HSL417
Westfall JM, McCabe J, Nicholas RA.
Personal use of drug samples by physicians and office staff.
JAMA 1997 Jul 9;278:(2):141-3
http://jama.ama-assn.org/cgi/content/abstract/278/2/141?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=1&author1=Westfall+JM&author2=Nicholas+RA&title=Personal+&andorexacttitle=and&andorexacttitleabs=and&andorexactfulltext=and&searchid=1124524024400_83&stored_search=&FIRSTINDEX=0&sortspec=relevance&journalcode=jama
HSL577
Cho M.
Disclosing conflicts of interest.
Lancet 1997 Jul 5;350:(9070):72-3
HSL6749
Promotional war for genital herpes drugs
MaLAM Australian News 1997 Jul-Aug;5:(7-8):2-3
HSL6750
Brown P.
Talking to patients—a dangerous road for industry?
Scrip Magazine 1997 Jul-Aug;(59):3-4
www.pjbpubs.co.uk/scrip/scrhome.html
HSL6751
Hayes L, Mintzes B.
The ties that bind: drug industry sponsorship
HAI-Lights 1997 Jul-Aug;2:(2-3):1-5
HSL6752
Sweet M.
Healthy profits: an overview of promotion in Australia
MaLAM International News 1997 Jul-Aug;15:(7-8):1-4
HSL8224
Briscoe AP, Pancerella MB, Pleskunas G.
Perfect order initiative
Pharmaceutical Executive 1997 Jul;17:82, 84, 86, 88
HSL8234
Navarro RP.
Dissecting drug cost trends.
Med Interface 1997 Jul;10:(7):80-2
HSL20319
J D Haug
Physicians' preferences for information sources: a meta-analytic study.
Bull Med Libr Assoc 1997 July;85:(3):223-232
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC226263/
HSL571
Davidoff F.
Where's the bias?
Ann Intern Med 1997 Jun 15;126:(12):986-8
http://www.acponline.org/journals/annals/15jun97/wherbias.htm
HSL2057
Shuchman M, Wilkes MS.
Medical scientists and health news reporting: a case of miscommunication.
Ann Intern Med 1997 Jun 15;126:(12):976-82
http://www.annals.org/cgi/content/full/126/12/976
HSL8321
Consumers receive written information with most prescriptions, report indicates.
Am J Health Syst Pharm. 1997 Jun 15;54:(12):1381, 1386, 1388
http://www.ajhp.org/cgi/reprint/54/12/1381
HSL420
[No authors listed]
Good manners for the pharmaceutical industry.
Lancet 1997 Jun 7;349:(9066):1635
http://linkinghub.elsevier.com/retrieve/pii/S0140673697210238
HSL519
Smith R.
Conflict of interest in clinical research: opprobium or obsession?
Lancet 1997 Jun 7;349:(9066):1703
http://www.thelancet.com/journals/lancet/article/PIIS0140673605626803/fulltext
HSL523
Scheifele DW.
Clinical trials and tribulations: a personal view of interacting with pharmaceutical manufacturers.
Clin Invest Med 1997 Jun;20:(3):188-92
HSL532
Palmlund I.
The marketing of estrogens for menopausal and postmenopausal women.
J Psychosom Obstet Gynaecol 1997 Jun;18:(2):158-64
HSL536
McElwain M.
Recent progress in drug advertising.
Can Fam Physician 1997 Jun;43:1041-2:
HSL541
Madhavan S, Amonkar MM, Elliott D, Burke K, Gore P.
The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians.
J Clin Pharm Ther 1997 Jun;22:(3):207-15
HSL566
Dukes MN.
The menopause and the pharmaceutical industry.
J Psychosom Obstet Gynaecol 1997 Jun;18:(2):181-8
Page 171 of 206 pages ‹ First < 169 170 171 172 173 > Last ›
